Autor: |
Congwei Gu, Zihan Zhou, Zehui Yu, Manli He, Lvqin He, Zhengzhong Luo, Wudian Xiao, Qian Yang, Fangfang Zhao, Weiyao Li, Liuhong Shen, Jianhong Han, Suizhong Cao, Zhicai Zuo, Junliang Deng, Qigui Yan, Zhihua Ren, Mingde Zhao, Shumin Yu |
Jazyk: |
angličtina |
Rok vydání: |
2022 |
Předmět: |
|
Zdroj: |
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022) |
Druh dokumentu: |
article |
ISSN: |
2235-2988 |
DOI: |
10.3389/fcimb.2022.870785 |
Popis: |
In recent years, nonalcoholic fatty liver disease (NAFLD) has become the most common liver disease in the world. As an important model animal, the characteristics of gut microbiota alteration in mice with NAFLD have been studied but the changes in metabolite abundance in NAFLD mice and how the gut microbiota affects these intestinal metabolites remain unclear. In this experiment, a mouse model for NAFLD was established by a high-fat diet. The use of 16S rDNA technology showed that while there were no significant changes in the alpha diversity in the cecum of NAFLD mice, the beta diversity changed significantly. The abundance of Blautia, Unidentified-Lachnospiraceae, Romboutsia, Faecalibaculum, and Ileibacterium increased significantly in NAFLD mice, while Allobaculum and Enterorhabdus decreased significantly. Amino acids, lipids, bile acids and nucleotide metabolites were among the 167 significantly different metabolites selected. The metabolic pathways of amino acids, SFAs, and bile acids were significantly enhanced, while the metabolic pathways of PUFAs, vitamins, and nucleotides were significantly inhibited. Through correlation and MIMOSA2 analysis, it is suggested that gut microbiota does not affect the changes of lipids and bile acids but can reduce thiamine, pyridoxine, and promote L-phenylalanine and tyramine production. The findings of this study will help us to better understand the relationship between gut microbiota and metabolites in NAFLD. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|